Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary. | Clin Adv Hematol Oncol;21 Suppl 6(12): 15-17, 2023 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary.

McGregor, Bradley A.

Affiliation

McGregor BA; Lank Center of Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Clin Adv Hematol Oncol ; 21 Suppl 6(12): 15-17, 2023 Dec.

Article in En | MEDLINE | ID: mdl-38307621

Subject(s)

Carcinoma, Transitional Cell; Medical Oncology; Humans; Carcinoma, Transitional Cell/drug therapy

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Medical Oncology Limits: Humans Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Medical Oncology Limits: Humans Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article